Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas
- PMID: 1334253
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas
Abstract
The receptor for Hepatocyte Growth Factor is a transmembrane tyrosine kinase encoded by the c-MET oncogene. We have previously shown that the Met protein is expressed in several human epithelial tissues. The receptor is barely detectable, however, in normal thyroids and in specimens from patients affected by non-neoplastic thyroid diseases. Now we report that the expression of the Met/HGF receptor is increased a hundred fold in 22 out of 41 human carcinomas derived from the thyroid follicular epithelium. A comprehensive analysis of 15 cases showed that the overexpressing carcinomas belong to histotype variants correlated with negative prognosis and in all but one case there were evidences of locally advanced disease and/or distant metastases. The 11 benign adenomas and the 5 medullary carcinomas tested were negative. Western blot analysis with monoclonal antibodies directed against either the intracellular or the extracellular receptor domains failed to reveal major structural alterations. Southern blot analysis also demonstrated that the c-MET gene was not amplified nor rearranged. These data suggest a role for the overexpression of c-MET oncogene in the pathogenesis and progression of thyroid tumors derived from the follicular epithelium.
Similar articles
-
Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.EXS. 1993;65:131-65. EXS. 1993. PMID: 8380735 Review.
-
Expression of the Met/HGF receptor in normal and neoplastic human tissues.Oncogene. 1991 Nov;6(11):1997-2003. Oncogene. 1991. PMID: 1719465
-
Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.Oncogene. 1991 Apr;6(4):501-4. Oncogene. 1991. PMID: 1827664
-
Transformation of thyroid epithelium is associated with loss of c-kit receptor.Cancer Res. 1995 Apr 15;55(8):1787-91. Cancer Res. 1995. PMID: 7536131
-
The hepatocyte growth factor and its receptor.Stem Cells. 1993 Jul;11 Suppl 2:22-30. doi: 10.1002/stem.5530110805. Stem Cells. 1993. PMID: 8401259 Review.
Cited by
-
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.Am J Pathol. 1999 Aug;155(2):517-26. doi: 10.1016/S0002-9440(10)65147-4. Am J Pathol. 1999. PMID: 10433944 Free PMC article.
-
Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction.J Cancer Res Clin Oncol. 2005 Dec;131(12):821-8. doi: 10.1007/s00432-005-0031-2. Epub 2005 Nov 15. J Cancer Res Clin Oncol. 2005. PMID: 16180024
-
Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44.Mol Cell Biol. 2000 May;20(10):3482-96. doi: 10.1128/MCB.20.10.3482-3496.2000. Mol Cell Biol. 2000. PMID: 10779338 Free PMC article.
-
Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression.Br J Cancer. 2004 Aug 16;91(4):703-6. doi: 10.1038/sj.bjc.6601988. Br J Cancer. 2004. PMID: 15266330 Free PMC article.
-
Bayesian Framework for Detecting Gene Expression Outliers in Individual Samples.JCO Clin Cancer Inform. 2020 Feb;4:160-170. doi: 10.1200/CCI.19.00095. JCO Clin Cancer Inform. 2020. PMID: 32097024 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous